AI Investigates Everything

68. Theo of Golden: The Secret of Zila (Contains Spoilers)

Spoiler Alert: contains spoilers for the ending of Alan Levy’s Theo of Golden. In this deep dive, we unmask the mysterious 86-year-old stranger who transformed the town of Golden, Georgia. While the world knows him as Theo, the quiet man returning lost pencil portraits.

67. Theo of Golden: The 86-Year-Old Who Broke the Internet (No Spoilers)

How did a self-published novel by a first-time author in his late 60s defy the entire publishing industry to skyrocket to #1 on the New York Times Best Seller list? In this episode of AI Investigates Everything, we’re diving into the "quiet" phenomenon of Theo of Golden by Alan Levy. With over a million copies sold and a staggering 4.9 rating on Audible, this book has become the ultimate "word-of-mouth" smash hit of 2026. We explore: * The "Slow Living" Rebellion: Why a story with no cellphones, no explosive drama, and no shocking twists is exactly what our fractured attention spans are craving. * Theo’s Mission: The simple, repetitive, and deeply moving journey of an 86-year-old man returning lost pencil portraits to the residents of Golden, Georgia. * Critics vs. Fans: Why professional reviewers point out "structural flaws" while readers call it a "modern hagiography" and a life-changing sanctuary. * The "Good Sadness": How the book alchemizes grief into creative generosity. Whether you’re looking for a digital detox or just your next favorite read, discover why this "mindfulness exercise disguised as fiction" is capturing the cultural zeitgeist. No spoilers included—just the vibes.

66. Is the Birth Rate "Crisis" Actually a Win?

Beyond the Panic: We’ve all seen the headlines about plummeting birth rates and the impending "demographic time bomb." But today, we’re flipping the script. By diving into the latest fertility data, we reveal that the steepest drop isn't a total collapse—it's the near-disappearance of teen pregnancies. Join us as we explore how this demographic shift is breaking cycles of poverty, saving state governments billions, and ushering in a new era of highly intentional parenting. Is a smaller, more stable generation exactly what society needs?

65. Does Diet Coke Kill Cancer?

Does Diet Coke Prevent Cancer? Investigating the "Kills Cancer cells" Claim Is your daily diet soda habit a health risk or a hidden lifesaver? 🥤 In this episode of AI Investigates Everything, we tackle one of the most polarizing health debates sparked by recent viral headlines. We go beyond the soundbites to examine the conflicting world of artificial sweetener science. In this episode, we explore: * The "Grass" Controversy: We break down the viral claim that Diet Coke kills cancer cells because it "kills grass" and look at the medical reality behind the comparison. * The Yale Study Breakthrough: Can diet soda actually improve survival? We analyze a major Yale Cancer Center study that found at least one serving of diet soda per day was associated with a 46% improvement in the risk of colon cancer recurrence or death. * The Carcinogen Debate: What does the 2023 IARC classification of aspartame as "possibly carcinogenic" (Group 2B) really mean for the average consumer?. * WHO vs. JECFA: Why do international health bodies seem to disagree on the safety of non-sugar sweeteners, and what are the current "safe" daily limits?. * Metabolic Impact: We investigate the link between artificial sweeteners, the gut microbiome, and insulin resistance to see if "zero calories" truly means zero harm. From White House diet habits to high-level oncology research, this episode provides the data-driven clarity you need to navigate the headlines. Subscribe to AI Investigates Everything for weekly deep dives into the science, myths, and technology shaping our world.

64. Pancreatic Cancer Survival Doubled

Summary: A biological fortress has finally been breached. We investigate the groundbreaking Phase 3 trial of Duraxonrib, a daily pill that has doubled the survival time for patients with advanced pancreatic cancer. Full Description: For thirty years, the five-year survival rate for advanced pancreatic cancer has been trapped at a grim 3%. In this investigation, we explore how scientists finally "picked the lock" of the RAS mutation—a protein once deemed "undruggable" due to its smooth, slippery shape. We break down the data showing survival jumping from 6.7 months on standard chemotherapy to 13.2 months with this new targeted therapy. Discover how this "molecular grease" was overcome and why this oral treatment is offering more than just time—it’s offering a higher quality of life. This podcast was AI generated and may be incomplete and contain mispronunciations or errors.